Received May 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
seizures; This serious case was reported by a consumer via interactive digital media and described the occurrence of seizure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced seizure (Verbatim: seizures) (serious criteria GSK medically significant). The outcome of the seizure was not reported. It was unknown if the reporter considered the seizure to be related to Shingles vaccine. The company considered the seizure to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 21-MAY-2026 This case was reported by a consumer via interactive digital media. The reporter stated that do not get the shingles vaccine if you have a history of pink eye, it could trigger a serious eye infection. The batch number was not provided and unable to contact the reporter.; Sender's Comments: A case of Seizure, on an unknown time after vaccination with unknown dose of Shingles vaccine, in a patient. Based on the available information a possible causality that the event was caused by GSK vaccine product cannot be ascertained. Consent for further follow up has not been received.